Event-Driven Stocks

Keros Therapeutics, Inc.

KROSNasdaqCompleted

ActivistActivist / 5%+ stake disclosed (SCHEDULE 13D/A)

Sector
Healthcare
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
State of incorporation
Form
SCHEDULE 13D/A
Filed
October 16, 2025

Filings & documents

Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.